Breakthrough Stem Cell Treatment For Pulmonary Hypertension Trialed
Researchers at the Medical School of Hanover (MHH) announced it was the “first successful treatment of stopping the usually fatal course of the disease in the world.” Pulmonary arterial hypertension (PAH) is high blood pressure in the blood vessels that supply the lungs. There is currently no cure for the condition that can affect people of all ages. Risk factors include family history, prior blood clots in the lungs, problems with the mitral valve, and sleep apnea....